Results 141 to 150 of about 16,042 (257)

Comprehensive screening for immunodeficiency-associated vaccine-derived poliovirus: an essential oral poliovirus vaccine cessation risk management strategy [PDF]

, 2016
Radboud J. Duintjer Tebbens, Kimberly M. Thompson   +1 more
openalex   +1 more source

Eradicació de la poliomielitis [PDF]

, 2014
Treballs Finals de Grau de Farmàcia, Facultat de Farmàcia, Universitat de Barcelona, 2014. Tutora: Núria Torner Gràcia.[cat] La poliomielitis és una malaltia viral infecciosa, d’importància mundial. Afecta a nens menor de 5 anys i pot produir paràlisis.
Jambrina Albiach, Anna Maria
core  

IMMUNIZATION OF NEWBORN CHILDREN WITH LIVING ORAL TRIVALENT POLIOVIRUS VACCINE [PDF]

, 1962
C. Campillo-Sainz, A. Ornelas Hernandez, J. De Mucha Macías, S. E. Nava   +3 more
openalex   +1 more source

Referee report. For: Complexity of options related to restarting oral poliovirus vaccine (OPV) in national immunization programs after OPV cessation [version 1; peer review: 1 approved, 2 approved with reservations]

, 2023
Matt A. Price
openalex   +1 more source

Do Childhood Vaccines Have Non-Specific Effects on Mortality [PDF]

, 2003
A recent article by Kristensen et al. suggested that measles vaccine and bacille Calmette–Guérin (BCG) vaccine might\ud reduce mortality beyond what is expected simply from protection against measles and tuberculosis.
Boyce , G. Thomas, Cooper, O. William, Griffin, R. Martin, Wright, F. Peter   +3 more
core  

The epidemiology of non-polio enteroviruses: recent advances and outstanding questions [PDF]

, 2015
Grassly, N, Parker, E, Pons Salort, M
core   +1 more source

Shedding of Vaccine Viruses with Increased Antigenic and Genetic Divergence after Vaccination of Newborns with Monovalent Type 1 Oral Poliovirus Vaccine

, 2009
Sabine van der Sanden, Mark A. Pallansch, Jan van de Kassteele, Nasr El-Sayed, Roland W. Sutter, Marion Koopmans, Harrie van der Avoort   +6 more
openalex   +2 more sources

Immunogenicity of type 2 monovalent oral and inactivated poliovirus vaccines for type 2 poliovirus outbreak response: an open-label, randomised controlled trial [PDF]

, 2018
Khalequ Zaman, Concepción F. Estívariz, Michelle Morales, Mohammad Yunus, Cynthia J. Snider, Howard E. Gary, William C. Weldon, M. Steven Oberste, Steven G. F. Wassilak, Mark A. Pallansch, Abhijeet Anand   +10 more
openalex   +1 more source

Global oral poliovirus vaccine stockpile management as an essential preparedness and response mechanism for type 2 poliovirus outbreaks following global oral poliovirus vaccine type 2 withdrawal.

Vaccine, 2023
Harutyunyan V, Quddus A, Pallansch M, Zipursky S, Woods D, Ottosen A, Vertefeuille J, Lewis I.   +7 more
europepmc   +1 more source

A Health Economic Analysis for Oral Poliovirus Vaccine to Prevent COVID-19 in the United States. [PDF]

Risk Anal, 2021
Thompson KM, Kalkowska DA, Badizadegan K.   +2 more
europepmc   +1 more source